Astrana Health (NASDAQ:ASTH) Trading Down 5.7% – What’s Next?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) traded down 5.7% on Tuesday . The company traded as low as $35.29 and last traded at $35.3360. Approximately 186,301 shares traded hands during trading, a decline of 66% from the average session volume of 553,827 shares. The stock had previously closed at $37.47.

Analysts Set New Price Targets

Several equities analysts recently issued reports on ASTH shares. Weiss Ratings upgraded Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 1st. BTIG Research boosted their price objective on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. TD Cowen upped their target price on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Truist Financial raised their target price on shares of Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research note on Monday. Finally, Barclays lifted their price target on shares of Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $49.43.

Astrana Health Stock Performance

The stock has a market cap of $1.92 billion, a P/E ratio of 41.97 and a beta of 0.87. The stock has a fifty day simple moving average of $41.36 and a 200-day simple moving average of $32.58. The company has a quick ratio of 1.35, a current ratio of 1.23 and a debt-to-equity ratio of 1.05.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. 325 Capital LLC increased its stake in Astrana Health by 54.0% in the fourth quarter. 325 Capital LLC now owns 1,839,076 shares of the company’s stock valued at $45,627,000 after purchasing an additional 645,123 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Astrana Health by 418.3% during the fourth quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock worth $18,331,000 after purchasing an additional 596,293 shares in the last quarter. Diamond Hill Capital Management LLC Investment Advisor bought a new position in shares of Astrana Health during the second quarter worth $22,088,000. Ameriprise Financial Inc. grew its holdings in shares of Astrana Health by 231.0% in the 3rd quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock valued at $12,540,000 after buying an additional 308,665 shares during the period. Finally, Bank of New York Mellon Corp acquired a new position in shares of Astrana Health in the 2nd quarter valued at $10,902,000. Institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.